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Gilles Francony f, Laurent Gergelé o, Carole Ichai p, Étienne Javouhey j,
Pierre-Etienne Leblanc q,r, Thomas Lieutaud s,t, Philippe Meyer u, Sébastien Mirek v,
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[SFAR]) in partnership with Association de neuro-anesthésie-réanimation de langue
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v Service d’anesthésie-réanimation, CHU de Dijon, Dijon, France
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§ French Society of Anaesthesia and Intensive Care Medicine, in collaboration with Anarlf, SFMU, SFNC, GFRUP, Adarpef, Association de neuro-anesthésie réanimation de
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A B S T R A C T
The latest French Guidelines for the management in the first 24 hours of patients with severe traumatic
brain injury (TBI) were published in 1998. Due to recent changes (intracerebral monitoring, cerebral
perfusion pressure management, treatment of raised intracranial pressure), an update was required. Our
objective has been to specify the significant developments since 1998. These guidelines were conducted
by a group of experts for the French Society of Anesthesia and Intensive Care Medicine (Société francaise
d’anesthésie et de réanimation [SFAR]) in partnership with the Association de neuro-anesthésie-réanimation
de langue française (ANARLF), The French Society of Emergency Medicine (Société française de médecine
d’urgence (SFMU), the Société française de neurochirurgie (SFN), the Groupe francophone de réanimation et
d’urgences pédiatriques (GFRUP) and the Association des anesthésistes-réanimateurs pédiatriques
d’expression française (ADARPEF). The method used to elaborate these guidelines was the Grade1
method. After two Delphi rounds, 32 recommendations were formally developed by the experts focusing
on the evaluation the initial severity of traumatic brain injury, the modalities of prehospital
management, imaging strategies, indications for neurosurgical interventions, sedation and analgesia,
indications and modalities of cerebral monitoring, medical management of raised intracranial pressure,
management of multiple trauma with severe traumatic brain injury, detection and prevention of post-
traumatic epilepsia, biological homeostasis (osmolarity, glycaemia, adrenal axis) and paediatric
specificities.
C 2017 The Authors. Published by Elsevier Masson SAS on behalf of Société française d’anesthésie et de
réanimation (Sfar). This is an open access article under the CC BY license (http://creativecommons.org/
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Stéphane David (Lyon), Nicolas Engrand (Paris), Dominique
Fletcher (Garches), Gilles Francony (Grenoble), Laurent Gergelé
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6. Introduction
The latest French guidelines for the management in the first
24 hours of patients with severe traumatic brain injury (TBI) were
published in 1998 [1]. Due to recent changes (intracerebral
monitoring, cerebral perfusion pressure management, treatment
of intracranial hypertension), an update was required. We would
like to highlight the major work done by experts in 1998 and advise
readers to refer to it. A large part of the 1998 guidelines remains
valid and we present updated recommendations in the present
material. These guidelines refer to the early management of severe
TBI, i.e. the first 24 hours after injury. Later management (> 24 hrs)
and mild and moderate TBI patients have not been taken into
consideration.
Guidelines for temperature control were not addressed in this
document because of the concomitant publication of French
guidelines on targeted temperature management in the ICU with a
specific focus on brain-injured patients [2].
7. Methodology
These guidelines were conducted by a group of experts for the
French Society of Anaesthesia and Intensive Care Medicine (Société
française d’anesthésie et de réanimation [SFAR] in partnership
with the Association de neuro-anesthésie-réanimation de langue
française [Anarlf], the French Society of Emergency Medicine
(Société Française de médecine d’urgence (SFMU), the Société
française de neurochirurgie [SFN], the Groupe francophone de
réanimation et d’urgences pédiatriques [GFRUP], and the Associa-
tion des anesthésistes-réanimateurs pédiatriques d’expression
française [Adarpef]). The organising committee defined a list of
questions to be addressed and designated experts in charge of each
question. The questions were formulated using the PICO (Patient
Intervention Comparison Outcome) format.
The method used to elaborate these guidelines was the GRADE1
method. Following a quantitative literature analysis, this method
was used to separately determine the quality of available evidence,
i.e. estimation of the confidence needed to analyse the effect of the
quantitative intervention, and the level of recommendation. The
quality of evidence was rated as follows:
 high-quality evidence: further research is very unlikely to
change the confidence in the estimate of the effect;
 moderate-quality evidence: further research is likely to have an
impact on the confidence in the estimate of the effect and may
change the estimate of the effect itself;
 low-quality evidence: further research is very likely to have an
impact on the confidence in the estimate of the effect and is
likely to change the estimate of the effect itself;
 very low-quality evidence: any estimate of the effect is very
unlikely.
The level of recommendation was binary (either positive or
negative), and strong or weak:
 strong recommendation: we recommend or we do not
recommend (Grade 1+ or 1);
 weak recommendation: we suggest or we do not suggest (Grade
2+ or 2).
The strength of the recommendations was determined accord-
ing to key factors and validated by the experts after a vote, usingthe Delphi and Grade Grid method that encompasses the following
criteria:
 the estimate of the effect;
 the global level of evidence: the higher the level of evidence, the
stronger the recommendation;
 the balance between desirable and undesirable effects: the more
favourable the balance, the stronger the recommendation;
 values and preferences: in case of uncertainty or large
variability, the level of evidence of the recommendation is
probably weak, and values and preferences must be more clearly
obtained from the affected persons (patient, physician and
decision-maker);
 cost: the greater the costs or the use of resources, the weaker the
recommendation.
The elaboration of a recommendation requires that at least 50%
of voting participants have an opinion and that less than 20% of
participants vote for the opposite proposition. The elaboration of a
strong agreement requires the agreement of at least 70% of voting
participants.
The guidelines on the management at the early phase of severe
TBI were analysed by 32 experts according to 11 topics:
 how to describe and evaluate the initial severity of traumatic
brain injury patients?
 what are the modalities of prehospital management for severe
traumatic brain injury patients?
 imaging strategies in severe traumatic brain injury patients;
 indications for neurosurgical interventions (cerebral monitoring
excluded);
 sedation and analgesia;
 indications and modalities of cerebral monitoring in severe
traumatic brain injury patients;
 medical management of raised intracranial pressure;
 management of multiple trauma with severe traumatic brain
injury;
 detection and prevention of post-traumatic seizures;
 biological homeostasis (osmolarity, glycaemia, adrenal axis);
 paediatric specificities of severe traumatic brain injury.
The pubMed and Cochrane databases were searched for
full articles written in English or French, and published after
1998. A specific analysis was performed for TBI in paediatric
patients.
The level of evidence of the literature focused on TBI is globally
associated with a weak level of methodology. The analysis of the
literature led to three situations:
 in the presence of clinical trials or meta-analyses with an
acceptable methodological quality, the GRADE1 method was
applicable;
 when no meta-analysis was available, a qualitative analysis by
the experts following the GRADE1 method was performed;
 in the absence of recent studies, no recommendation was
made.
After the implementation of the GRADE1 method, 32 recom-
mendations were formally developed by the organising commit-
tee: 10 were strong (Grade 1 ), 18 were weak (Grade 2 ), and
4 were expert opinions because GRADE1 methodology was not
applicable.
All recommendations were submitted to a reviewing group for a
Delphi method assessment. After 2 rounds of voting and evaluation
and after various amendments, a strong agreement was reached
for 32 (100%) recommendations.
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brain injury patients?
R1.1 – We recommend assessing the severity of traumatic
brain injury using the Glasgow coma scale, specifically the
motor response, as well as pupillary size and reactivity.
Grade 1+, Strong agreement
Argument:
The initial clinical evaluation of severe TBI has not signifi-
cantly changed since the 1998 French Guidelines [1].
Age, initial Glasgow coma scale, and pupillary size and
reactivity are key issues of the neurological outcome at
6 months, even in the recent studies [3–10]. The IMPACT
[11] and CRASH [12] studies, including respectively 6681
and 8509 patients, have validated these criteria.
The Glasgow coma scale must be described according to
each of the 3 components, according to the original descrip-
tion, i.e. Eye-Verbal-Motor response [13,14].
However, the correlation between the Glasgow coma score
and outcome has become less evident in recent studies [6]. The
extensive use of sedation and tracheal intubation on scene has
disabled the assessment of eye and verbal responses. The
motor component remains robust in sedated patients and it is
well correlated with the severity of head trauma. A simplified
assessment of TBI patients based on the motor response has
been proposed [11,15–23].
In order to detect secondary neurological aggravation, clini-
cal examination has to be repeated during the initial manage-
ment of the patient [24–26]. The rhythm of this recurrent
examination is left at the discretion of the in-charge physician,
but it must be continued after the hospital admission [5,24].
Moderate TBI patients, i.e., with a Glasgow coma score
between 9 and 13, have a significant risk of secondary neuro-
logical degradation [5]. In this situation, the rhythm of neuro-
logical examination can be planned every hour in Australia
[27]; every 30 min for the first 2 hours and then every hour
during the 4 following hours in the United Kingdom [28]; or
every 15 min during the first 2 hours and then every hour for
the following 12 hours in Scandinavia [29]. The occurrence of a
secondary neurological deficit or a decrease of at least two
points in the Glasgow coma score should lead to a second CT
scan [27–30].
R1.2 – We recommend investigating and correcting systemic
factors of secondary cerebral insults.
Grade 1+, Strong agreement
Argument:
Arterial hypotension at the initial phase of TBI is a key issue
associated with a poor prognosis at 6 months [11,31]. The
Traumatic Coma Data Bank showed that the occurrence of
episodes of arterial hypotension (systolic blood pressu-
re < 90 mmHg) for at least 5 minutes was associated with a
significant increase in neurological morbidity and mortality
[32]. Prehospital and intrahospital arterial hypotension is as-
sociated with an increased mortality [33–35]. The 2014 French
Guidelines on haemorrhagic shock recommended maintaining
a mean arterial pressure  80 mmHg in severe TBI patients.
Hypoxemia occurs in approximately 20% of patients with
traumatic brain injury [35]. It is associated with increased
mortality and aggravated neurological outcome. The IMPACT
study found that the presence of hypoxia was significantly
associated with poor neurological outcome at 6 months
[11]. Furthermore, the duration of hypoxemic episodes
(SaO2  90%) is an important predictor of mortality [36].
The association of arterial hypotension and hypoxemia
appears to be particularly deleterious with a 75% mortality
rate [37].
Protocols on the detection and correction of these secondary
insults are associated with an improvement of the outcome ofbrain-injured patients [1,38]. A retrospective study comparing
before-after implementation of protocols focused on intracra-
nial pressure monitoring and the prevention of secondary
insults found a significant reduction in mortality after such
implementation [39].
R1.3 – We recommend assessing the initial severity of trau-
matic brain injury on clinical and radiological criteria (CT scan).
Grade 1+, Strong agreement
Argument:
Brain and cervical CT scans should be performed systemati-
cally and without delay in any severe (Glasgow coma
scale  8), or moderate (Glasgow coma scale 9–13) TBI.
Patients with mild TBI (Glasgow coma scale 14–15) should
have a brain CT scan if they meet the followings: signs of
fracture of the basal skull (rhinorrhoea, otorrhea, haemotym-
pan, retroauricular haematoma, periorbital haematoma), dis-
placed skull fracture, post-traumatic epilepsy, focal
neurological deficit, coagulation disorders, anticoagulant ther-
apy [25,28–30].
R1.4 – We suggest using transcranial Doppler to assess the
severity of traumatic brain injury.
Grade 2+, Strong agreement
Argument:
In TBI patients, cerebral perfusion pressure (CPP) may be
estimated by the calculation of Pulsatility Index (PI), a parame-
ter derived from the measurement of diastolic, systolic and
mean blood flow velocities [40]. Transcranial Doppler (TCD)
has gained interest to estimate brain haemodynamics in the
intensive care unit. However, there are limited data on the use
of TCD in patients with traumatic brain injury upon their arrival
at the hospital. These studies found an association between
higher mortality rate and a mean blood flow velocity (Vm)
below 28 cm/s [41] or a combination of a low Vm and high PI
[42]. In 36 children, a diastolic blood flow velocity (Vd) of less
than 25 cm/s or a PI greater than 1.3 was associated with poor
outcome [43]. After moderate or mild TBI patients (Glasgow
coma score 9–14), PI value on admission was higher in patients
with a secondary neurological degradation within the first
week post-trauma [44]. In a subsequent study, thresholds
for predicting secondary neurological degradation in this
population were 25 cm/s for Vd and 1.25 for PI [45]. In severe
TBI patients (Glasgow score < 9), a strategy based on TCD
measurements on admission to the emergency room was
described [46]: if the patient had Vd < 20 cm/s and PI > 1.4,
therapeutic measures were taken to improve brain perfusion.
Using TCD on arrival at the hospital should be part of the
initial assessment of multiple trauma patients, and be included
in the Focused assessment with sonography for trauma
(FAST).
R1.5 – We do not suggest using biomarkers in clinical routine
to assess the initial severity of traumatic brain injury patients.
Grade 2-, Strong agreement
Argument:
In addition to the initial assessment using the Glasgow coma
scale (GCS) and brain CT imaging, the use of biomarkers has
been proposed to provide more information on the severity of
TBI.
An association was found between neurological outcome at
3 and 6 months and the following biomarkers: plasma S100b
[47,48], neuron specific enolase (NSE) [49,50], ubiquitin C-
terminal hydrolase-L1 (UCH-L1) [51–53], glial fibrillary protein
acid (GFAP) [48,49], myelin-basic protein (MBP) [54,55] and tau
protein [56]. Similar findings were observed in the cerebrospi-
nal fluid with S100b protein [47], UCH-L1, SBDPs [57,58] and
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performance of these biomarkers, particularly serum biomark-
ers, to evaluate the initial severity of TBI patients [60].
9. What are the modalities of prehospital management for
severe TBI patients?
R2.1 – We recommend managing severe TBI patients by a pre-
hospital medicalised team on scene and transferring them as
soon as possible to a specialised centre including neurosurgi-
cal facilities.
Grade 1+, Strong agreement
Argument:
In trauma injuries, TBI was shown to mostly benefit from
admission to specialised centres in terms of survival rates [61–
69]. The management of severe TBI patients in a specialised
neuro-intensive care was associated with improved outcome
[70,71].
In a retrospective study comparing two periods (before/after
the creation of a neuro-intensive care unit), the neurological
outcome was significantly improved in the latter period, after
adjusting for other factors such as Glasgow coma scale, age, or
occurrence of arterial hypotension upon arrival [70]. For ill-
nesses with the same severity, the mortality rate was lower in
neurosurgical centres compared to non-specialised centres,
even for patients who did not require neurosurgical procedure.
[68]. This is due to expertise accumulated from large inflows of
these patients and to the availability of neurosurgeons. The
non-specialised centres should be able to early detect patients
who need a transfer to a specialised centre.
R2.2 – In adults, we suggest maintaining a systolic blood
pressure > 110 mmHg prior to measuring cerebral perfusion
pressure.
Grade 2+, Strong agreement
Argument:
The neurological outcome is undoubtedly worsened after a
single episode of hypotension (systolic blood pressu-
re < 90 mmHg) during the early phase of TBI [72–75]. More
recently, mortality rate was found markedly raised where
systolic blood pressure dropped below 110 mmHg at admis-
sion [63,76,77].
Prevention of any episode of arterial hypotension is critical:
no hypotensive hypnotic agent to induce sedation, continuous
sedation rather than bolus of sedatives, correction of hypo-
volaemia if needed, mechanical ventilation adjusted to facili-
tate central venous return [78–80]. Rapid correction of arterial
hypotension should include vasopressor drugs such as phen-
ylephrine and norepinephrine. Decreasing doses of sedatives
or increasing fluids may have delayed effects on haemodyna-
mics. Catecholamines can be initially infused through an
indwelling catheter in a peripheral vein.
R2.3 – We recommend controlling the ventilation of severe
traumatic brain injury patients throughout tracheal intuba-
tion, mechanical ventilation, and end Tidal CO2 monitoring
even during the pre-hospital period.
Grade 1+, Strong agreement
Argument:
Airway control is a priority and pre-hospital tracheal intuba-
tion decreases mortality of trauma patients [81–83]. The arterial
partial pressure of CO2 (PaCO2) has a strong impact on cerebral
circulation. Hypocapnia induces cerebral vasoconstriction, and
is a risk factor for brain ischaemia [82,84]. Monitoring of end-
tidal CO2 (EtCO2) in intubated patients is critical to check the
correct placement of tracheal tube, to maintain PaCO2 within anormal range and to detect a possible decrease in cardiac output
[85–88]. An EtCO2 between 30–35 mmHg is recommended prior
to getting arterial gas samples to adjust mechanical ventilation.
10. Imaging strategies in severe traumatic brain injury patients
R3.1 – We recommend performing a brain and cervical com-
puted tomography (CT) scan without delay in severe traumatic
brain injury patients.
Grade 1+, Strong agreement
Argument:
The exploration of the entire brain with nested, inframillime-
tric sections reconstructed with a thickness of more than one
millimetre is the reference CT method in TBI.
The sections should be visualised with double fenestration,
i.e., central nervous system and bones.
Due to its availability, the CT scan is the first choice to make
the diagnosis of the primary brain lesions [89]. It must be
carried out without delay in case of coma or abnormal neuro-
logical examination. The initial CT scan can guide neurosurgi-
cal procedures and monitoring techniques [90,91].
R3.2 – We suggest performing an early exploration of the
supra-aortic and intracranial arteries using CT-angiography in
patients with risk factors.
Grade 2+, Strong agreement
Argument:
The risk factors for traumatic dissection of supra-aortic and
intracranial arteries are [92]:
 presence of a fracture of the cervical spine;
 focal neurological deficit not explained by brain imaging;
 Claude Bernard-Horner syndrome;
 Lefort II or III type facial fractures;
 fractures of the basal skull;
 soft tissue lesions at the neck.
These risk factors should lead to an exploration of the supra-
aortic and intracranial vessels by CT-angiography. Even in the
absence of these risk factors, indications of this exam can be
extended, especially in the most severe patients in whom the
neurological examination may be limited [93,94]. In case of a
strong suspicion of arterial dissection, a normal CT-angiogra-
phy should be completed with a MR-angiography or a digital
subtraction angiography [95–97].
11. Indications for neurosurgical interventions (cerebral
monitoring excluded)
R4.1 – We suggest performing external ventricular drainage to
treat persisting intracranial hypertension despite sedation and
correction of secondary brain insults.
Grade 2+, Strong agreement
Argument:
Drainage of cerebrospinal fluid (CSF) from normal or small
volume ventricles is a therapeutic option to control intracranial
pressure. Although mentioned in studies [98], the efficacy of
this procedure lacks strong evidence. Subtraction of a small
volume of CSF may reduce markedly the intracranial pressure.
External ventricular drain can be inserted using neuronaviga-
tion [99].
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hypertension, the removal of brain contusions with mass effect
is also an option [100].
The neurosurgical indications at the early phase of severe
TBI patient are:
 removal of a symptomatic extradural haematoma
whatever its location,
 removal of a significant acute subdural haematoma
(thickness greater than 5 mm with displacement of the
median line greater than 5 mm),
 drainage of acute hydrocephalus
 closure of open displaced skull fracture.
 a closed displaced skull fracture with brain compression
(thickness > 5 mm, mass effect with displacement of
the median line > 5 mm).
R4.2 – We suggest performing a decompressive craniectomy
to control intracranial pressure at the early phase of TBI where
refractory intracranial hypertension in a multidisciplinary dis-
cussion.
Grade 2+, Strong agreement
Argument:
Four clinical trials including more than 1000 patients have
investigated theefficacy ofdecompressivecraniectomyafter TBI
[101–104]. The place of craniectomy in the therapeutic strategy
varied across studies, i.e. used as a rescue strategy in refractory
intracranial hypertension, or early, in the first 72 hours, before
the initiation of therapeutic hypothermia and barbiturates. The
most commonly used technique is a large temporal craniectomy
(> 100 cm2) with enlarged dura mater plasty. The bifrontal
craniectomy, indicated in patients with diffuse lesions, was used
in some studies. Aging was an exclusion criterion with a
threshold set at 60 years (1 study), 65 years (2 studies) and
70 years (1 study). The decision must be taken on a case-by-case
basis.Goodoutcome, asdefinedby the Glasgow Outcome Scale
(GOS) score of 4 or 5 at 6 months post-trauma, were 28–32% in
the control group versus 40–57% after a unilateral craniectomy
(P = 0.03) [102,103]. In the DECRA study, a bifrontal craniectomy
was associated with poor outcome: the extended GOS (E-GOS)
score of 1–4 (poor outcome) measured at 6 months, was 51% in
the control group versus 70% in the intervention group (P = 0.02)
[104]. The RESCUE-ICP study included patients with refractory
intracranial hypertension and randomised patients to undergo
either decompressive craniectomy (201 patients) or barbiturates
coma (188 patients). In the decompressive craniectomy group,
the mortality rate was reduced to 26.9% (vs. 48.9% in the medical
group), at the expense of more patients with poor neurological
outcome (8.5% versus 2.1%). Favourable outcome at 6 months
was not different between the two groups: 26.6% in the medical
group versus 27.4% in the intervention group [105].
12. Sedation and analgesia
R5.1 – Apart from the treatment of intracranial hypertension
and convulsive status epilepticus, the maintenance and ces-
sation of sedation and analgesia in patients with severe TBI
should follow the guidelines for non-brain injured patients.
Experts’ opinion
Argument:
The current guidelines on sedation and analgesia in the ICU
[106] should be extended to stabilised brain-injured patients.
Although scarcely studied, the use of clinical scores and the
implementation of protocols to manage sedation and analge-
sia may provide benefits [107,108]. The daily interruption of
sedation may be deleterious to cerebral haemodynamics inpatients with low intracranial compliance [109,110]. No evi-
dence was found that one sedative or opioid agent provided
more efficacy than another in TBI patients. Arterial hypoten-
sion can be observed with barbiturates [111], bolus of mida-
zolam [112] or bolus of opioids [113]. Attention should be paid
to the control of systemic haemodynamics in the choice of
drugs and their modalities of administration. Insufficient data
exist with the use of halogenated agents and dexmedetomi-
dine in TBI patients.
13. Indications and modalities of cerebral monitoring in severe
traumatic brain injury patients
R6.1 – We suggest monitoring intracranial pressure (ICP) after
severe TBI to detect intracranial hypertension in the following
cases:
 signs of high ICP on brain CT scan;
 extracranial surgical procedures (except life-threat-
ening conditions);
 neurological evaluation not feasible.
Grade 2+, Strong Agreement
Argument:
Although the benefit of ICP monitoring on patient outcome
has not been clearly demonstrated, this technique has become
an integral part of the management of severe TBI patients
[114]. Retrospective and observational studies have estimated
the risk of intracranial hypertension after severe TBI [115–
118]. The incidence of high ICP varies between 17 and 88%
[119–122]. An ICP of 20–40 mmHg is associated with a higher risk
of 3.95 (95% confidence interval [1.7–7.3]) of mortality and poor
neurological outcome [123]. Above an ICP of 40 mmHg, mortali-
ty risk is 6.9 times higher (95% confidence interval [3.9–12.4]).
The impact of intracranial hypertension on the outcome
requires the use of ICP monitoring in patients whose neuro-
logical assessment is not feasible.
When the initial CT-scan is abnormal, more than 50% of
patients will present intracranial hypertension [115]. Among
the usual CT scan criteria of intracranial hypertension, i.e. the
disappearance of cerebral ventricles, brain midline shift over
5 mm, intracerebral haematoma volume over 25 mL [124], the
compression of basal cisterns appears to be the best sign to
reflect intracranial hypertension [119]. The absence of basal
cisterns is associated with an ICP higher than 30 mmHg in more
than 70% of cases [125]. However, their visibility cannot
exclude intracranial hypertension [126]. The presence of trau-
matic subarachnoid haemorrhage is associated with a risk of
intracranial hypertension [126].
In the case of emergency extracranial surgery, apart from
life-threatening surgery, several studies found a high incidence
of cerebral hypoperfusion due to arterial hypotension associat-
ed with high ICP. A decrease in intraoperative cerebral perfusion
pressure below 70 mmHg and 50 mmHg was found in 26–74%
of patients [127,128] and in 45% of patients [129], respectively.
This reduced perfusion pressure aggravates primary and sec-
ondary brain lesions and worsens brain oedema [130–132].
R6.2 – We do not suggest monitoring intracranial pressure if
the initial CT-scan is normal with no evidence of clinical
severity, and/or transcranial Doppler abnormalities.
Grade 2-, Strong Agreement
Argument:
Although a normal CT-scan cannot exclude the risk of
subsequent intracranial hypertension in comatose patients,
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CT-scan is normal (0–8%) [133–135]. Recent advances in CT
scan imaging may explain the good performance of CT to rule
out intracranial hypertension [136,137].
ICP monitoring, particularly with the reference method of
intraventricular drain, is associated with complications: catheter
placement failure (10%) [115,138], infection (10% for intraven-
tricular drains [139] and 2.5% for intraparenchymal fiberoptic
devices [140]), and intracerebral haemorrhage (2–4% for intra-
ventricular drains and 0–1% for intraparenchymal fiberoptic
devices [115,141]). Moreover, the benefit of ICP monitoring
has not been clearly demonstrated. The randomised controlled
study BEST-TRIP (347 patients) found no difference in neurolog-
ical outcome between ICP monitoring and clinical surveillance
with repeated CT-scans [142]. Although the external validity of
this study is lacking, the results of that study should be consid-
ered. In severe TBI patients with strictly normal initial CT-scan,
the risk-benefit balance does not support indication for invasive
ICP monitoring. If the neurological surveillance is not feasible
and/or if the patient has haemodynamic instability, the risk-
benefit balance should be considered on a case-by-case basis.
If ICP monitoring is indicated, intraparenchymal probes may be
preferred over intraventricular drains (risk-benefit balance).
R6.3 – We suggest monitoring ICP after post-traumatic intra-
cranial haematoma evacuation (subdural, epidural or intrapa-
renchymal) in the case of (only 1 criterion is required):
 preoperative Glasgow Coma Scale motor response
inferior or equal to 5;
 preoperative anisocoria or bilateral mydriasis;
 preoperative haemodynamic instability;
 preoperative severity signs on cerebral imaging
(compressed basal cisterns, brain midline shift over
5 mm, presence of other intracranial lesions);
 intraoperative cerebral oedema;
 postoperative appearance of new intracranial lesions
on cerebral imaging.
Grade 2+, Strong Agreement
Argument:
No randomised study has evaluated the benefit of postop-
erative ICP monitoring after evacuation of post-traumatic
intracranial haematoma (subdural, epidural or intraparenchy-
mal). However, in that situation, the incidence of postoperative
intracerebral haematoma ranges between 50% [143] and 70%
[144]). More than 40% of these patients will have uncontrolla-
ble intracranial hypertension [144,145], following haemodyna-
mic instability [146] or initial neurological signs of severity such
as preoperative Glasgow Coma Scale motor response inferior
or equal to 5, anisocoria, or haematoma volume greater than
25 mL [147]. An increase in ICP may be due to secondary
bleeding after decompression or reperfusion, to a new ex-
tra-axial collection, or to an increased brain oedema. Retro-
spective studies have found benefits of postoperative ICP
monitoring after decompressive craniectomy [148,149].
R6.4 – Multimodal monitoring with transcranial Doppler and/
or brain tissue oxygenation pressure measurements may be
used to optimise cerebral blood flow and oxygenation in
severe TBI patients.
Experts’ opinion
Argument:
Transcranial Doppler cannot be considered as a non-inva-
sive ICP monitoring. Nevertheless, a weak relationshipbetween the pulsatility index and cerebral perfusion pressure
was found [150–152]. Voulgaris et al. [153] found that the
pulsatility index measurement can detect patients at risk of
reduced cerebral perfusion pressure. Transcranial Doppler can
also exclude the risk of severe intracranial hypertension with a
negative predictive value of 88% for a 1.26 cut-off for pulsatility
index [154].
Brain tissue oxygenation pressure (PbtiO2) reflects the
oxygen supply and diffusion in the interstitial space of brain
tissue. The risk for brain ischaemia has been set for PbtiO2
less than 15 mmHg [155]. This risk of ischaemia is also
linked to the duration of hypoxic episodes. The time spent
under the ischaemic threshold is a determinant factor for
irreversible damage. Van den Brink et al. have proposed
different ischaemic thresholds: < 5 mmHg for 30 min,
< 10 mmHg for 1 hr and 45 min, < 15 mmHg for 4 hrs
[156]. PbtiO2 is correlated with local cerebral blood flow,
cerebral perfusion pressure, haemoglobin content and
PaO2. A brain tissue response to hyperoxia can be observed.
A strong reactivity to oxygen challenge may reflect a loss of
cerebral autoregulation [157].
PbtiO2 monitoring is gaining interest to prevent cerebral
ischaemia despite normal cerebral perfusion pressure. This
monitoring can be used to determine an optimal cerebral
perfusion pressure [158]. This strategy might allow optimis-
ing treatment during the evolution course of the brain insult.
Narotam et al. [159] have retrospectively compared the
outcome (survival and neurological outcome at 6 months)
after the implementation of a PbtiO2 protocol to maintain
PbtiO2 higher than 20 mmHg. An improvement in the out-
come was found in this group by comparison with the
historical control group managed with intracranial pres-
sure/cerebral perfusion pressure protocol. Similar findings
were found by Spiotta et al. [160]. However, the uncontrolled
and retrospective nature of these studies cannot allow draw-
ing definitive conclusions on the interest of PbtiO2 in TBI
patients.
14. Medical management of raised intracranial pressure
R7.1 – We suggest individualising the objectives of intracranial
pressure and cerebral perfusion pressure.
Grade 2+, Strong Agreement
Argument:
The level of ICP associated with poor neurological prognosis
is variable in the literature. An ICP higher than 20–25 mmHg is
usually admitted as a criterion to initiate therapies. Retrospec-
tive and prospective studies have determined ICP values
associated with unfavourable outcome [161–168], but effects
of ICP monitoring on outcome varied [169–171]. The duration
of high ICP is a factor of poor prognosis [172,173], but the
direct benefit of ICP monitoring remains controversial
[142,174,175]. Moreover, no definite ICP threshold was associ-
ated with outcome [176–178]. In this context, recent studies
argue in favour of an individualised treatment based on beat-
by-beat cerebral autoregulation assessment from the relation
between ICP and mean arterial pressure (Pressure Reactivity
Index or PRx) [162,163,179–182].
The ‘‘optimal’’ cerebral perfusion pressure (CPP) would
correspond to the CPP value for which the autoregulation of
cerebral blood flow shows the best vascular response. Recent
studies found that the best outcome could be obtained when
the actual CPP is close to the optimal calculated CPP
[179,180,182,183]. Any deviation from this optimal CPP was
associated with poor outcome. These studies support an
individualised approach of CPP according to autoregulation
status.
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pressure between 60 and 70 mmHg in the absence of multi-
modal monitoring.
Grade 2+, Strong Agreement
Argument:
Measurement of ICP allows the determination of cerebral
perfusion pressure (CPP) (CPP = MAP-ICP). In the absence of
consensus, it is recommended to place the reference point to
measure MAP at the external ear tragus [184,185]. A
CPP > 70 mmHg is not recommended in routine for all
patients. In one randomised controlled trial comparing a
strategy maintaining CPP > 70 mmHg versus a strategy main-
taining an ICP < 20 mmHg and a CPP > 50 mmHg, the high CPP
group had a 5 times higher incidence of respiratory distress
syndrome, while no effect was found on the neurological
outcome [186]. A CPP < 60 mmHg has been shown to be
associated with poor outcome [162,164,165,177,178].
A CPP value higher than 90 mmHg was associated with a
worsening of the neurological outcome, due to a possible
aggravation of vasogenic cerebral oedema [165].
One studycompared two strategies conducted in two centres in
Sweden and Scotland. In Sweden, the primary objective was
keeping the ICP < 20 mmHg and the CPP around 60 mmHg as a
secondary objective (low CPP), while in Scotland, the primary
objective aimed at maintaining the CPP > 70 mmHg and
PIC < 25 mmHg as a secondary objective (high CPP) [181].
Patientswithalteredcerebralautoregulationhadabetteroutcome
with the ICP-based protocol (low CPP). Patients with preserved
autoregulationhadabetteroutcomewiththeCPP-basedprotocol.
In another retrospective study, CPP < 60 mmHg was associated
with a better prognosis when autoregulation was impaired [187].
R7.3 – We recommend using mannitol 20% or hypertonic
saline solution, at a dose of 250 mOsm, in infusion of 15–
20 minutes to treat threatened intracranial hypertension or
signs of brain herniation after controlling secondary brain
insults.
Grade 1+, Strong Agreement
Argument:
Osmotherapy causes a transient increase in the osmolarity
of the extracellular space, inducing an osmotic pressure gra-
dient on the blood-brain barrier and a water displacement to
the hypertonic environment. Osmotherapy reduces the intra-
cranial pressure (ICP) with a maximum effect observed after
10–15 minutes and for a duration of 2–4 hours, in order to
restore cerebral blood flow (CBF). Of the three therapies that
decreased ICP, i.e. mannitol, external ventricular drainage, and
hyperventilation, mannitol only was associated with improved
cerebral oxygenation [188]. Outside the hospital, osmotherapy
is the treatment of choice in patients with signs of brain
herniation (mydriasis, anisocoria) and/or neurological wors-
ening not attributable to a systemic cause. On the other hand, a
prophylactic administration of hypertonic saline solution to
patients with no evidence of intracranial hypertension was not
superior to crystalloids regarding the outcome [189,190].
At equiosmotic dose (about 250 mOsm), mannitol and
hypertonic saline (HS) have comparable efficacy to treat intra-
cranial hypertension [191,192]. Side effects of these osmotic
agents should be considered: mannitol induces osmotic diure-
sis and requires volume compensation while HS exposes to
hypernatremia and hyperchloremia. In both cases, monitoring
fluid, sodium and chloride balances is necessary.
R7.4 – We do not suggest using prolonged hypocapnia to treat
intracranial hypertension.
Grade 2-, Strong Agreement
Argument:
Hypocapnia was one of the first-line options to treat intra-
cranial hypertension. The only prospective randomised studythat studied the effect of severe and prolonged hypocapnia
(25  2 mmHg for 5 days) compared to normocapnia
(35  2 mmHg) found worsened neurological outcome in the
hypocapnic group [193]. This deleterious effect is due to the
exacerbation of secondary ischaemic lesions even for moder-
ate hypocapnia (30 mmHg), decreased cerebral blood flow and
increased oxygen extraction, with inconsistent effects on ce-
rebral metabolism [84,194–197]. Thus, prolonged and/or se-
vere hyperventilation to control intracranial hypertension is
not recommended in the absence of cerebral oxygen measure-
ment to ensure that cerebral hypoxia is not induced by this
procedure.
R7.5 – We do not suggest using 4% albumin solution in severe
TBI patients.
Grade 2-, Strong Agreement
Argument:
The SAFE study [198], that recruited nearly 7000 patients,
compared the administration of 0.9% saline serum versus 4%
albumin in patients admitted to intensive care. At 28 days, no
difference in mortality or organ failure was found between the
two groups. However, severe TBI patients who received 4%
albumin solutionhad higher mortalityrates thanthose with0.9%
saline serum (24.5% vs. 15.1%, RR: 1.62, CI 95%: 1.12–2.34,
P = 0.009). A subgroup analysis conducted by Myburgh et al.
[199]witha2-yearfollow-upof460patients(including318severe
TBI) found an increased risk of mortality after albumin adminis-
tration (41.8% vs. 22.2%, respectively; RR: 1.88, 95% CI 1.31–2.7,
P < 0.001).Thehypotonicnatureofthe4%albumin infusionmay
have played a role. If severe TBI is associated with haemorrhagic
shock, the use of albumin is not recommended [200]. The
European Society of Intensive Care Medicine (ESICM) did not
recommend using albumin solution after brain injury [201].
15. Management of multiple trauma with severe traumatic
brain injury
R8.1 – In multiple trauma with severe TBI, a whole body CT-
scan is considered once haemodynamics and respiratory
function are stabilised.
Experts’ opinion
Argument:
In trauma patients with haemodynamic instability, the inci-
dence of neurosurgical lesions is low compared to lesions
requiring urgent surgical haemostasis (2.5% vs. 21%) [202]. In
unstable patients, haemostasis and haemodynamics should
be stabilised prior to considering a whole body CT-scan.
Although the benefits of a whole body CT-scan on mortality
in severe trauma patients did not reach significance (RR: 0.91,
95% CI: 0.79–1.05) [203], the whole-body CT-scan was found
more effective to reduce mortality rate in severe trauma
patients compared to segmental CT-scan [204,205].
R8.2 – Apart from life-threatening conditions requiring urgent
surgery, haemorrhagic procedure is not recommended in the
context of intracranial hypertension.
Experts’ opinion
Argument:
In severe TBI patients, major surgery with haemorrhage, low
arterial blood pressure and blood transfusion can contribute to
secondary insults to the brain and aggravate the initial injury
and cerebral oedema, increase the risk of developing severe
lung injury or even multiple organ failure [130,132,206].
Non-haemorrhagic surgical procedures, e.g. orthopaedic
surgery, can be performed early (less than 24 hours) in stabi-
lised brain-injured patients in the absence of intracranial
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brain injury, none found increased mortality or poor neurolog-
ical outcome with early surgical procedures [206,130].
R8.3 – We suggest measuring intracranial pressure during
extracranial surgical procedure in severe TBI patients.
Grade 2+, Strong Agreement
Argument:
The neurological monitoring of these patients is essential to
limit episodes of decreased cerebral perfusion pressure.
Pietropaoli et al. studied the haemodynamic effects of ex-
tracranial surgery in the first 72 hours after severe TBI
[207]. Thirty-two percent of patients had episodes of intra-
operative arterial hypotension (systolic blood pressu-
re < 90 mmHg). These patients had a mortality of 82%,
whereas patients without intraoperative arterial hypoten-
sion had a mortality of 32%.
16. Detection and prevention of post-traumatic seizures
R9.1 – We do not suggest using antiepileptic drugs for primary
prevention to reduce the incidence of post-traumatic seizures
(early and delayed).
Grade 2-, Strong Agreement
Argument:
In the study of Annegers et al. on post-traumatic seizure, the
incidence of early clinical seizures (within 7 days after the brain
injury) was 2.2%, the incidence of delayed seizures (after 7 days)
was 2.1%, but it was 11.9% in the first year for the severe TBI
patients [208]. This retrospective study with 4541 minor, mod-
erate and severe TBI did not mention the use of antiepileptic
prophylaxis or electroencephalogram recordings. In this study,
risk factors for delayed clinical seizures were brain contusion,
acute subdural haematoma, skull fracture, initial loss of con-
sciousness or amnesia for more than 24 hours and age over
65 years [208,209]. The occurrence of early seizures did not
expose to late seizures in the multivariate analysis. More
recently, craniectomy has been identified as a possible risk
factor for early post-traumatic seizures [210,211].
The study by Temkin et al. [212] and ancillary studies
[213,214] have been integrated in the bibliographic analysis,
given their importance.
Eleven clinical trials studied primary prevention of post-
traumatic seizures: 2 compared phenytoin versus placebo or
no treatment (1101 patients) [215,216], 7 phenytoin versus
levetiracetam (1392 patients) [217–223], and 2 valproate versus
phenytoin or no treatment (291 patients) [224,225]. Three
studies were prospective and 8 retrospective. Three studies
included electroencephalogram recordings [217,218,220]. Two
meta-analyses have been added [226,227]. Apart from the
study by Radic et al. [222], including acute and subacute
subdural haematomas, none of these studies specifically
assessed aforementioned risk factors for post-traumatic sei-
zure.
All studies had a low level of evidence. Apart from the
Cochrane 2015 meta-analysis, which was in favour of phenyt-
oin prevention to early post-traumatic seizures including many
studies published before 1998 [227], no significant effect of
antiepileptic drugs (AEDs) was found to prevent the occurrence
of early or delayed post-traumatic seizures. Moreover, in-
creased side effects of phenytoin were shown
[218,219,222,223,227] or even a worsening of the neurological
outcome with AEDs [214,216,218].
Overall, prevention of post-traumatic seizures with AEDs
cannot be recommended. It can be considered in case of risk
factors, e.g. chronic subdural haematoma, or past history of
epilepsy. In this case, levetiracetam should be preferred to
phenytoin, because of a higher degree of tolerance.There is no specificity in the treatment of seizures or epi-
lepticus status after severe TBI.
17. Biological homeostasis (osmolarity, serum glucose, adrenal
axis)
R10.1 – In adults, we do not suggest using prolonged hyper-
natremia to control intracranial pressure in severe TBI
patients.
Grade 2-, Strong Agreement
Argument:
Hypertonic Saline (HS)-induced hypernatremia is derived
from the effects of bolus of HS to decrease ICP. A continuous
infusion of HS to induce serum hyperosmolarity is postulated
as effective to decrease cerebral oedema and ICP, and possibly
to improve the outcome. However, there is no trial to validate
this hypothesis. In paediatrics, the HS group required fewer
interventions to maintain ICP < 15 mmHg than a control group
receiving Ringer lactate [228]. However, serum sodium
concentrations and osmolarity in the HS group were not
reported. There are arguments not in favour of the use of
controlled hypernatremia after TBI:
 the theoretical beneficial effect of hypernatremia
supposes an intact blood-brain barrier (BBB) to create
an osmotic gradient. The perfusion of HS could be
deleterious with disrupted BBB by increasing the size of
cerebral contusions [229];
 the rapid regulation of the brain cell volume limits the
effectiveness of a prolonged hyperosmolarity: intracel-
lular osmoles are synthetised to restore normal cell
volume. There is then a risk of a ‘‘rebound’’ of ICP during
the correction of hypernatremia;
 the relationship between serum sodium and ICP is weak
[230];
 hypernatremia is associated with hyperchloremia
hyperchlor, which may be deleterious for the renal
function. However, these side effects were not found in a
retrospective analysis of 50 TBI patients with controlled
hypernatremia [231].
R10.2 – We do not recommend using high-dose glucosteroids
after severe TBI.
Grade 1-, Strong Agreement
Argument:
The CRASH study, with more than 10,000 TBI patients, found
a higher mortality rate in the high-dose glucocorticoid group
vs. placebo [232].
R10.3 – We recommend the maintenance of serum glucose
concentration between 8 mmol/L (1.4 g/L) and 10–11 mmol/L
(1.8–2 g/L) in severe TBI patients (adults and children).
Grade 1+, Strong agreement
Argument:
Hyperglycaemia is not uncommon after a severe TBI. This
stress-related hyperglycaemia is induced by counter-regula-
tion hormones and/or insulin resistance [233]. Observational
studies have clearly shown that hyperglycaemia after a TBI is
associated with an increased risk of mortality and poor neuro-
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cose > 11 mmol/L (2 g/L) has been identified as an indepen-
dent risk factor of mortality, infection and prolonged duration
in the ICU, after adjustment for age and severity score
[234,236]. Hyperglycaemia is considered as a secondary insult
to the injured brain tissue.
In general ICU, the initial positive results of strict glycaemic
control [242] were not further confirmed [243]. The increased
risk of hypoglycaemia associated with intensive insulin ther-
apy cannot be neglected. Using cerebral microdialysis, insulin
therapy with a glycaemic control < 6 mmol/L (1.1 g/L) was
associated with a decrease in interstitial brain glucose con-
centration [244–248]. Concomitant elevations of interstitial
brain concentrations of lactate, glutamate, and lactate/pyru-
vate ratio suggested a cerebral energy crisis that may aggra-
vate the initial injury. A randomised, crossover study with
13 TBI patients showed that a strict control of serum glucose
(4.4–6.1 mmol/L or 0.8–1.1 g/L) resulted in increased cerebral
metabolism and elevation of markers of energy crisis com-
pared to a liberal strategy (6.6–8.3 mmol/L or 1.2–1.5 g/L)
[249].
Seven randomised controlled trials have assessed the
effects of glycaemic control in TBI patients [242,250–255]. All
found that a strict control of serum glucose did not improve the
neurological outcome or mortality, while the risk of hypogly-
caemia is increased. In 88 severe TBI, a higher incidence of
hypoglycaemia was observed in the group with a strict control
of serum glucose (4.4–6.1 mmol/L or 0.8–1.1 g/L) [253]. Al-
though no difference in mortality at day 28 or neurological
outcome at 6 months was found between 2 targeted concen-
trations of serum glucose, i.e. 5.9 mmol/L (1.1 g/L) vs 6.5 mmol/
L (1.2 g/L), episodes of severe hypoglycaemia were more
frequent in the strict control group [255]. Similar conclusions
were observed in a post-hoc analysis of TBI patients from the
NICE-SUGAR study, [254]. A meta-analysis published in
2012 with 1248 TBI patients [256] found no benefit of a strict
glucose control on mortality (RR: 0.99, 95% CI [0.79–1.22]) and a
greater risk of hypoglycaemia (RR: 3.1, 95% CI [1.54–6.23],
P = 0.002).
Overall, a targeted serum glucose concentration between
8 mmol/L (1.4 g/L) and 10 mmol/L (1.8 g/L) is recommended
for TBI patients. That implies regularly measuring blood
glucose concentrations from venous or arterial blood sam-
ples.
18. Paediatric specificities of severe traumatic brain injury
R11.1 – We suggest measuring ICP after paediatric severe TBI,
including inflicted TBI in infants.
Grade 2+, Strong agreement
Argument:
Recent studies with severe brain-injured children indicated
that ICP monitoring might have a positive impact on neurolog-
ical outcome [257–260] although this effect cannot be separat-
ed from the global management of patient. In addition, studies
[163,261–276] found that the level of cerebral perfusion pres-
sure was more correlated with the outcome than the isolated
value of ICP.
ICP monitoring is less performed in children < 2 years old
[258,277,278]. The inflicted trauma represents a prominent
cause of TBI in this subgroup [277,278]. This population is
however at risk for high ICP and poor outcome [258,279–
282]. In TBI children < 2 years old, the incidence of raised
ICP was found high and a strong association existed between
cerebral perfusion pressure and neurological outcome
[283,284]. The ICP-related complication rates in children and
infants did not differ from adults [285,286].R11.2 – We suggest setting the minimum cerebral perfusion
pressure value according to the age: 40 mmHg for children of
0 to 5 years old, 50 mmHg for 5 to 11 years old and between
50 and 60 mmHg for children older than 11 years old.
Grade 2+, Strong agreement
Argument:
Children with cerebral perfusion pressure (CPP) below
40 mmHg were at higher risk of poor prognosis, including
death or severe disability, considering the time spent below
this CPP threshold [163,273,287,288]. Although no study had
explored the impact of a guided-strategy maintaining
CPP > 40 mmHg, an association was found between favou-
rable outcome and CPP thresholds according to the patient age
[266,274,276]. Children of 0–5 years and of 6–11 years with
CPP < 30 mmHg and < 35 mmHg, respectively, were 8 times
more likely to have a poor outcome than those with
CPP > 40 mmHg and > 50 mmHg, respectively [276]. Children
of 12–17 years with CPP < 50 mmHg had a 2.35-times higher
risk of poor outcome than those with CPP > 60 mmHg [276].
The minimal CPP threshold associated with a reduced risk of
death was 55 mmHg and 60 mmHg for children of 8 and 7 years,
respectively [264,274]. For 10 years old children, the optimal
CPP was 58 mmHg [266]. It should be noted that a minimal CPP
value does not mean an optimal CPP, which should be ex-
plored for each patient.
The relationship between ICP measurements and outcome
in children was explored with therapies initiated if
ICP > 20 mmHg. These studies consistently found a strong
correlation between ICP  20 mmHg and favourable outcome
based on Glasgow Outcome Scale measurements (no, minor
or moderate disability) [261–263,268–270,272,289]. A strong
association was observed between ICP > 40 mmHg (or some-
times 35 mmHg) and unfavourable outcome (death, vegetative
state, severe disability) [163,261,262,266,268,272,273,290]. Ac-
cordingly, the 2012 American Guidelines [291] confirmed that
treatment of high ICP in children should be considered if ICP
exceeded 20 mmHg. However, some data suggest that this ICP
threshold should be lower in young children. Physiologically,
ICP and CPP are reduced in proportion to the children age while
comparable values to adults are observed after 6–8 years of age
[292]. This supports strategies considering age-related ICP
values [163,266,273,290]. If the association between ICP values
and outcome is dependent on the age, ICP should be maintai-
ned below 20 mmHg in the younger group [271]. However,
further studies are needed to confirm these data.
R11.3 – We recommend managing severe TBI children in a
paediatric trauma centre or in an adult trauma centre with
paediatric expertise.
Grade 1+, Strong argument
Argument:
The management of severe trauma children, especially
severe TBI, in a paediatric trauma centre or by default in an
adult trauma centre with paediatric expertise, was associated
with a reduced morbidity and mortality [293–305].
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